Sun Pharmaceutical Industries Limited, a specialty generic pharmaceutical company, announced the retirement of Kalyanasundaram Subramanian as Whole-time Director of the company, with effect from February 13, 2023. According to the company’s exchange filing, “The term of Mr. Kalyanasundaram Subramanian (DIN: 00179072), Whole-time Director would end on February 13, 2023, and accordingly he shall retire from…